Gene L Robinson, MD | |
1915 E Rezanof Dr, Kodiak, AK 99615-6602 | |
(907) 486-9580 | |
(907) 486-9586 |
Full Name | Gene L Robinson |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1915 E Rezanof Dr, Kodiak, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023034139 | NPI | - | NPPES |
00D0063349 | Other | HMSA | |
054955-01 | Medicaid | HI | |
C63341 | Other | LIMSA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 6785 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gene L Robinson, MD 1915 E Rezanof Dr, Kodiak, AK 99615-6602 Ph: (907) 486-9580 | Gene L Robinson, MD 1915 E Rezanof Dr, Kodiak, AK 99615-6602 Ph: (907) 486-9580 |
News Archive
Researchers at the University of Pennsylvania School of Medicine have discovered that an enzyme produced by lung-infecting bacteria further shuts down a protein that is defective in cystic fibrosis patients.
Chemists at The Scripps Research Institute (TSRI) have devised a new technique for connecting drug molecules to antibodies to make advanced therapies.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
Researchers have identified a new area of the brain that responds to the fat hormone leptin in regulating body weight and energy expenditure. They said that the region seems to be particularly important in enabling the body to resist weight gain from a high-fat diet.
› Verified 7 days ago